graphic of a black bridge outline with a path of connected blue lines and text to the right "from discovery to recovery" above light green box with "Kahlart institute for addiction medicine NEWS" and blue to white gradient background

February 2025

Dear Colleague,

Welcome to the latest edition of our Kahlert Institute for Addiction Medicine newsletter. Stay updated with the latest news and events.


The Kahlert Team

Kahlert Institute for Addiction Medicine joins NIDA CCTN Appalachian Node


We are excited to announce that we have joined the Appalachian Node of the National Institute on Drug Abuse Clinical Trials Network and look forward to contributing to its research.

Sarah Kattakuzhy, MD, is our site principal investigator helping to ensure our active participation in this CTN.


To learn more about how the Kahlert Institute for Addiction Medicine is leveraging the most advanced research and clinical care to overcome addiction, please visit addiction.umaryland.edu

Kahlert Institute for Addiction Medicine Annual Symposium

Keynote Speakers:


Gary Aston-Jones, PhD

Professor, Rutgers University


Anna Konova, PhD

Assistant Professor, Robert Wood Johnson Medical School, Rutgers University


📅 Date: Wednesday, May 28, 2025

📍 Location: SMC Campus Center, 621 W. Lombard St., MD 21201

 

Join us for a day of insightful discussions, innovative research presentations, and networking opportunities.


Click here for more information

OR

Check out the event flyer to learn more about keynote and featured speakers

Upcoming Seminars

MACS Webinar: Optimizing the Pharmacy Partnership in Managing Patients With OUD

 

Thursday, February 6 | 12:00 p.m. – 1:00 p.m.

Presenter: Bethany DiPaula, PharmD, BCPP, FASHP, MACS Consultant

Learning Objectives:

By the end of the session, participants will be able to:

  1. Describe innovative roles for pharmacists in managing patients with OUD
  2. Identify barriers to managing patients with OUD in the community pharmacy
  3. State strategies to optimize access to mOUD in community pharmacies


Click here to register

SCORCH Consortium’s Virtual Meeting

 

Monday, February 10 | 12:00 p.m. – 5:00 p.m.


The Single Cell Opioid Responses in the Context of HIV (SCORCH) consortium meeting is a virtual event focusing on HIV, addiction, and single-cell technologies and highlighting the findings and resources made available through the SCORCH consortium. More information can be found on the SCORCH consortium website.


Click here to learn more

Register

Yale Program in Addiction Medicine Grand Rounds



Tuesday, February 11 | 12:00 p.m. – 1:00 p.m


Learning Objectives:

1. Describe opportunities to advance the health of people who use drugs in diverse political climates

2. Identify opportunities to leverage syringe service programs to bring comprehensive HIV services to people who use drugs.

3. Understand a harm reduction approach to health care for people who use drugs.

Register

NIH Heal Initiative, NIDA & NIMH


HEAL Workshop: Health Economics Research to Address the Needs of Those With Serious Mental Illness, Substance Use Disorder, and Comorbid Conditions

 

Friday, February 14 | 10:00 a.m. – 3:45 p.m

Register

Department of Neurobiology Seminar Series


Presenter: Dr. Julian Guarque-Chabrera

Hosted by: Marco Venniro, PhD

Date: February 18, 2025

Location: Hosick Lecture Hall, Bressler Research Building

 

Zoom link: Click here

Meeting ID: 985 7025 8800

Grayken Center for Addiction Training & Technical Assistance


Alcohol Use Disorders 101

Friday, February 21 | 10:00 a.m. – 11:00 a.m.


Objectives:

  1. Participants will understand the epidemiology of alcohol use and alcohol use disorders in the U.S.
  2. Identify diagnostic criteria and at least two screening tools for assessment.
  3. Describe three evidence-based interventions and treatment approaches for AUDs.
Register

Kahlert Institute Seminar Series

Event Topic: Psycho-social & Behavioral Interventions


Date: March 12, 2025, 12:00 p.m. 1:00 p.m.

Location: Hosick Hall, Bressler Research Building, 655 W. Baltimore Street

"The Role of Social Behavior on Substance Use Disorders"


Marco Venniro, PhD

Assistant Professor

Department of Neurobiology

University of Maryland School of Medicine

"Supporting Behavior Change in Persons With Substance Use Disorders"


Melanie Bennett, PhD

Professor

Division Director for the Division of Psychiatric Research Services (DPSR)

Department of Psychiatry

University of Maryland School of Medicine

Lunch will be provided

Click here to submit your questions for the panel discussion

Opioid Industry Documents Archive

Purdue Settlement in Principle Announced


Purdue/Sackler settlement under consideration includes document disclosure requirement

 

The proposed $7.4 billion settlement with members of the Sackler family and their company, Purdue Pharma (Purdue), includes a provision for document disclosure, which would require Purdue to make public more than 30 million documents related to Purdue and the Sacklers’ opioid business.

 

According to the Office of the Massachusetts Attorney General, if the settlement is approved, the documents are “expected to be added to the existing public document repository” (UCSF-JHU Opioid Industry Documents Archive) that already houses millions of documents from multiple industries responsible for the crisis.

 

UCSF and Johns Hopkins University are pleased that these vitally significant documents are one step closer to being made public. The Opioid Industry Documents Archive provides evidence on how and why this crisis happened so that this type of tragedy can be prevented from occurring again. 

 

We look forward to having the opportunity to contribute our expertise in public health, digital archives, and information technology to enable timely and free public access to these important documents.

Series on PBMs and CVS cite OIDA

 

Reporter Catherine Dunn continued her series in Barron's on PBMs (pharmacy benefit managers) and opioids with "UnitedHealth and CVS Received Millions in Opioid Rebates Through Medicare." The article makes generous use of OIDA documents!

 

GoLocalProv gave OIDA a shout-out in the latest article in their series on Helena Foulkes, CVS, Purdue, and opioids.

Funding Opportunities

FY26 MOOR Competitive Grant Program - Now Accepting Proposals


This Competitive Grant Program aims to distribute funding to the highest-scoring proposals that align with Maryland’s strategic overdose response priorities and address areas of greatest need across the state. 

Key Dates

  • Call for Proposal Release Date: Monday, January 6, 2025
  • Application Deadline: Friday, February 28, 2025
  • Award Decisions: Wednesday, May 3, 2025 (tentative)
  • Anticipated Period of Performance: July 1, 2025 – June 30, 2026


Click here for more information



column pillars in white with yellow dash on top and red on bottom with "university of maryland school of medicine kahlert institute for addiction medicine" in white to the right
Email  LinkedIn